SeaStar Medical Holding Corp - 8-K Filing
SeaStar Medical reports Q3 2026 net revenue of $0.6M, a 247% increase YoY driven by QUELIMMUNE therapy adoption. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)